Singapore develops robotic for amassing swab samples


Singapore, September 21

Singapore has developed a robotic that carries out nasal swabbing to diagnose Covid-19 in a bid to cut back healthcare employees’ threat of publicity to the lethal coronavirus.

Clinicians from the National Cancer Centre Singapore (NCCS) and Singapore General Hospital (SGH) have partnered with Biobot Surgical, a agency specialising in medical robotics expertise, to develop SwabBot.

The self-administered robotic, that automates assortment of Covid-19 swab checks, will assist cut back healthcare employees’ threat of publicity to the coronavirus, it mentioned.

The robotic helps tackle the restrictions of guide swab checks by decreasing the necessity for educated manpower, standardising the consistency of the swabs taken and “providing greater throughput” of swab checks because the robotic doesn’t undergo from fatigue, the three teams mentioned in a press release.

SwabBot is a “self-administered” robotic, that means sufferers can activate and terminate the method at will. When a affected person is prepared, they will use their chin to activate the robotic and begin the swabbing course of.

The robotic then extends the swab via the nostril to the again of the nasal cavity, which is often about 10cm from the nostrils. — PTI



Be the first to comment on "Singapore develops robotic for amassing swab samples"

Leave a comment

Your email address will not be published.


*


%d bloggers like this: